The Australian market is showing resilience as the ASX200 is set to open slightly higher, even amid global economic concerns ...

As the Australian market navigates recent fluctuations, with the ASX200 slightly down at 8,308 points due to a sell-off in consumer discretionary stocks and banking shares, investors are closely ...

Integral Diagnostics (ASX: IDX) and Australian Clinical Labs (ASX ... “If some of those great growth quality stocks we have ...

These three ASX 200 outperformers have surged 17% to 28% this week! The post 3 ASX 200 stocks rocketing higher in this week's ...

Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with ...

After being up as much as 5%, the ASX growth stock is on course to end the day flat. This follows the release of the online (and now offline) beauty retailer's half year results. Adore Beauty ...

With dividend yields at 25-year lows, it's time to rethink ASX stocks for income according to James Gruber.

The Australian share market has ended lower on Wednesday, a day after the RBA delivered a long-awaited rate cut, while wages ...

Plato, Hyperion and Resolution Capital share their top stock ideas to play some of the market's hottest themes.

Passive income investors will be pleased by the 26% lift the ASX 200 stock just delivered on its interim dividend. Here’s what’s happening.

Shares closer lower; new jobs hit 44,000, topping forecasts; Megaport soars 19pc; banks slump; Magellan down 10pc; Fortescue, ...

Integral Diagnostics (ASX: IDX) had a great year in 2024; its share price was up around 50% as its business recovered from ...